ivosidenib 250 MG Oral Tablet

RxCUI: 2049878
RxNorm name: ivosidenib 250 MG Oral Tablet
Display name: ivosidenib 250 MG Oral Tablet
Full name: ivosidenib 250 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TIBSOVO	IVOSIDENIB	Servier Pharmaceutical LLC	65d254c0-67ad-42c4-b972-ad463b755b2d	2025-12-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2049878

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
65d254c0-67ad-42c4-b972-ad463b755b2d	ivosidenib 250 MG Oral Tablet [PSN] · ivosidenib 250 MG Oral Tablet [SCD]	2	11	These highlights do not include all the information needed to use TIBSOVO safely and effectively. See full prescribing information for TIBSOVO. TIBSOVO ® (ivosidenib tablets), for oral use Initial U.S. Approval: 2018	20251222